IUSTI Europe position statement on use of DoxyPEP: June 2024.
Sherrard, J
; Gokengin, D; Winter, A; Marks, M; Unemo, M; Jensen, JS; Cusini, M; Mårdh, O; IUSTI Europe Guideline Board and
(2024)
IUSTI Europe position statement on use of DoxyPEP: June 2024.
International journal of STD & AIDS, 35 (13).
pp. 1087-1089.
ISSN 0956-4624
DOI: 10.1177/09564624241273801
; Gokengin, D; Winter, A; Marks, M; Unemo, M; Jensen, JS; Cusini, M; Mårdh, O; IUSTI Europe Guideline Board and
(2024)
IUSTI Europe position statement on use of DoxyPEP: June 2024.
International journal of STD & AIDS, 35 (13).
pp. 1087-1089.
ISSN 0956-4624
DOI: 10.1177/09564624241273801
This position statement is aimed at front-line clinical practitioners and public health authorities in WHO European Region providing services for people wishing to reduce their risk of acquiring sexually transmitted infections (STIs), including HIV.
-
picture_as_pdf - Sherrard_etal_2024_DOXYPEP-Position-Statement-paper.pdf
-
subject - Published Version
-
error - This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads